Novavax, Inc. is a company in the U.S. stock market and it is a holding in 103 U.S.-traded ETFs. NVAX has around 4.9M shares in the U.S. ETF market. The largest ETF holder of NVAX is the Vanguard Small-Cap ETF (VB), with approximately 623.16K shares. Investors may also find of interest that the ETF with the largest allocation to NVAX stock is ETFMG Treatments Testing and Advancements ETF (GERM), with a portfolio weight of 4.20%. On average, U.S. ETFs allocate 0.42% of NVAX to their portfolios.

Additionally, NVAX is a favorite stock for Vanilla and Active ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with NVAX as a holding is the iShares Morningstar Value ETF (ILCV), with a return of 169.62%.